http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113501773-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J63-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-12
filingDate 2021-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-113501773-B
titleOfInvention Beta-ketone sulfoxide derivative of carboxylic acid drugs and preparation method and application thereof
abstract The invention provides a beta-ketone sulfoxide derivative of carboxylic acid drugs, a preparation method and application thereof, belonging to the technical field of organic synthesis. Using acyl chloride derivatives of carboxylic acids as raw materials in CaC 2 Preparation of beta-ketosulfoxide derivatives of this class of drugs in the Presence of TEA, in one aspect, in CaC 2 Under the coexistence of TEA, the yield of the prepared beta-keto sulfoxide derivative is up to 49-64%, and the beta-keto sulfoxide derivative is green and environment-friendly, mild in reaction process and simple to operate. On the other hand, the prepared beta-keto sulfoxide derivative is used as a medicine for treating respective indications, has less stimulation to intestines and stomach after entering a human body, and has the advantages of high activity, low toxicity and high added value.
priorityDate 2020-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3862214-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112939828-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546412
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415769162
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415752263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493149
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6326
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536333
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453041053
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID79668
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID288571
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44093
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534469
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107807
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10114
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552671
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419511919

Total number of triples: 38.